VistaGen Therapeutics Inc Cash Flow-to-Debt Ratio
VistaGen Therapeutics Inc cash flow-to-debt ratio. VistaGen Therapeutics Inc (VTGN) has a Cash Flow-to-Debt Ratio of -1.24x as of March 2026, meaning its operating cash flow of $-16.20 Million could theoretically repay -1% of its total liabilities ($13.04 Million) in one year. Check VistaGen Therapeutics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of VistaGen Therapeutics Inc (2008–2026)
Cash flow-to-debt ratio of VistaGen Therapeutics Inc from 2008 to 2026. Historical debt coverage capacity for VistaGen Therapeutics Inc across 19 annual periods. Check total reinvestment intensity of VistaGen Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
VistaGen Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2008–2026)
VistaGen Therapeutics Inc cash flow-to-debt ratio by year from 2008 to 2026. Year-by-year debt coverage analysis for VistaGen Therapeutics Inc. For the full cash flow conversion analysis, see VistaGen Therapeutics Inc (VTGN) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -5.09x | $-66.44 Million | $13.04 Million | ▼ -68.8% |
| 2025 | -3.02x | $-42.10 Million | $13.95 Million | ▼ -9.5% |
| 2024 | -2.76x | $-25.81 Million | $9.37 Million | ▲ +50.1% |
| 2023 | -5.52x | $-49.72 Million | $9.01 Million | ▼ -21.1% |
| 2022 | -4.56x | $-45.26 Million | $9.93 Million | ▼ -515.5% |
| 2021 | -0.74x | $-12.07 Million | $16.30 Million | ▲ +45.9% |
| 2020 | -1.37x | $-15.76 Million | $11.50 Million | ▲ +34.6% |
| 2019 | -2.09x | $-14.53 Million | $6.94 Million | ▼ -0.8% |
| 2018 | -2.08x | $-9.06 Million | $4.36 Million | ▲ +11.5% |
| 2017 | -2.35x | $-7.26 Million | $3.10 Million | ▼ -93.5% |
| 2016 | -1.21x | $-4.81 Million | $3.97 Million | ▼ -811.1% |
| 2015 | -0.13x | $-2.77 Million | $20.81 Million | ▲ +18.3% |
| 2014 | -0.16x | $-2.13 Million | $13.06 Million | ▲ +36.9% |
| 2013 | -0.26x | $-3.46 Million | $13.44 Million | ▲ +56.3% |
| 2012 | -0.59x | $-3.57 Million | $6.05 Million | ▲ +72.6% |
| 2011 | -2.15x | $-6.88K | $3.20K | ▲ +85.8% |
| 2010 | -15.17x | $-22.76K | $1.50K | ▼ -182.3% |
| 2009 | -5.37x | $-14.43K | $2.69K | ▲ +73.2% |
| 2008 | -20.06x | $-4.81K | $240.00 | — |